Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: Relevance to molecular epidemiology studies of glutathione S-transferase polymorphisms

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 937-943

  Hecht, Stephen S ^a   Villalta, Peter W ^a   Hochalter, J Bradley ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; GLUTATHIONE TRANSFERASE; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DETOXIFICATION; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE LEVEL;

ACETYLCYSTEINE; BIOTRANSFORMATION; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE TRANSFERASE; HUMANS; METABOLIC DETOXICATION, DRUG; MODELS, MOLECULAR; NEOPLASMS; PHENANTHRENES; POLYMORPHISM, GENETIC; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 47249132099     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn015     Document Type: Article

References (51)

1. Phillips,D.H. (1983) Fifty years of benzo[a]pyrene. Nature, 303 468-472.
2. Conney,A.H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res., 42, 4875-4917.
3. Pfeifer,G.P. et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21 7435-7451.
4. International Agency for Research on Cancer. (1985) Polynuclear aromatic compounds. Part 4. Bitumens, coal-tars and derived products, shale oils and soots. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon, Vol. 35, pp. 83-241.
5. International Agency for Research on Cancer. (1984) Polynuclear aromatic compounds. Part 3. Industrial exposures in aluminum production, coal gasification, coke production, and iron and steel founding. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon, Vol. 34, pp. 101-131.
6. International Agency for Research on Cancer. (1983) Polynuclear aromatic compounds. Part 1. Chemical, environmental and experimental data. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon, Vol. 32, pp. 419-430.
7. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
8. Hecht,S.S. (2003) Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat. Rev. Cancer, 3, 733-744.
9. Straif,K. et al. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol., 6, 931-932.
10. Dipple,A. et al. (1984) Polynuclear aromatic hydrocarbons. In Searle,C.E. (ed.) Chemical Carcinogens. 2nd edn. ACS Monograph 182. American Chemical Society, Washington, DC, Vol. 1, pp. 41-163.
11. Szeliga,J. et al. (1998) DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol., 11, 1-11.
12. Geacintov,N.E. et al. (1997) NMR solution structures of stereoisomeric covalent polycyclic aromatic carcinogen - DNA adducts: principles, patterns, and diversity. Chem Res. Toxicol., 10, 112-146.
13. Casale,G.P. et al. (2001) Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol., 14, 192-201.
14. Jiang,H. et al. (2006) Competing roles of aldo-keto reductase 1A1 and cytochrome P4501B1 in benzo[a]pyrene-7,8-diol activation in human bronchoalveolar H358 cells: Role of AKRs in P4501B1 induction. Chem. Res. Toxicol., 19, 68-78.
15. Boysen,G. et al. (2003) Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat. Res., 543, 17-30.
16. Cooper,C.S. et al. (1983) The metabolism and activation of benzo[a]pyrene. Prog. Drug Metabol., 7, 295-396.
17. Sundberg,K. et al. (2002) Glutathione conjugation and DNA adduct formation of dibenzo[a,l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases. Chem. Res. Toxicol., 15, 170-179.
18. Sundberg,K. et al. (2001) Expression of human glutathione transferases in V79 cells and the effect on DNA adduct-formation of diol epoxides derived from polycyclic aromatic hydrocarbons. Chem. Biol. Interact., 133, 91-94, 2-28.
19. Sundberg,K. et al. (1998) Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19, 433-436.
20. Sundberg,K. et al. (1997) Glutathione conjugation of bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase M1-1 and P1-1. Chem. Res. Toxicol., 10 1221-1227.
21. Dreij,K. et al. (2002) Catalytic activities of human alpha class glutathione transferases toward carcinogenic dibenzo[a,l]pyrene diol epoxides. Chem. Res. Toxicol., 15, 825-831.
22. Sundberg,K. et al. (2000) Studies on the differential inhibition of glutathione conjugate formation of (+)-anti-benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxide and 1-chloro-2,4-dinitrobenzene in V79 Chinese hamster cells. Biochem J., 3, 693-696.
23. Bartsch,H. et al. (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev., 9, 3-28.
24. Smith,G.B. et al. (2001) Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: Impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev., 10, 839-853.
25. Benhamou,S. et al. (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 23, 1343-1350.
26. Hung,R.J. et al. (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis, 24, 875-882.
27. Vineis,P. et al. (2004) CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: A pooled analysis of gene-gene interactions. Biomarkers 9, 298-305.
28. Stucker,I. et al. (2002) Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis, 23, 1475-1481.
29. Wang,Y. et al. (2003) Association between glutathione S-transferase pl polymorphisms and lung cancer risk in Caucasians: A case-control study. Lung Cancer, 40, 25-32.
30. Cote,M.L. et al. (2005) Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study. Carcinogenesis, 26, 811-819.
31. Lewis,S.J. et al. (2002) GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett., 180, 165-171.
32. Nazar-Stewart,V. et al. (2003) A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer, 40, 247-258.
33. Wang,J. et al. (2003) GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett. 201, 185-193.
34. Skuladottir,H. et al. (2005) Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer, 48, 187-199.
35. Schwartz,A.G. et al. (2007) The molecular epidemiology of lung cancer. Carcinogenesis, 28, 507-518.
36. Nordquist,M. et al. (1981) Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol. Pharmacol., 19, 168-178.
37. Thakker,D.R. et al. (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In Anders,M.W. (ed.) Bioactivation of Foreign Compounds. Academic Press, Inc., New York, pp. 177-242.
38. Shou,M. et al. (1994) Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett., 83, 305-313.
39. LaVoie,E.J. et al. (1988) Structure-activity relationships among tricyclic polynuclear aromatic hydrocarbons. In Yang,S.K. and Silverman,B.D. (eds.) Polycyclic Aromatic Hydrocarbon Carcinogenesis: Structure-Activity Relationships. CRC Press, Boca Raton, FL, Vol. 1, pp. 151-175.
40. Hecht,S.S. et al. (2006) Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol. Biomarkers Prev., 15, 1805-1811.
41. Hecht,S.S. et al. (2005) Longitudinal study of urinary phenanthrene metabolite ratios: Effect of smoking on the diol epoxide pathway. Cancer Epidemiol. Biomarkers Prev., 14, 2969-2974.
42. Hecht,S.S. et al. (2003) r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: A potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol. Biomarkers Prev. 12, 1501-1508.
43. Lee,H. et al. (1981) Stereoselective syn epoxidation of the dihydrodiols of dibenz[a,h]anthracene and 7-methylbenz[a]anthracene. Tetrahedron Lett., 22, 1657-1660.
44. Eaton,D.L. et al. (1999) Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 49, 156-164.
45. Glatt,H. et al. (1993) Genotoxicity characteristics of reverse diol-epoxides of chrysene. Carcinogenesis, 14, 11-19.
46. Buening,M.K. et al. (1979), Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice. Cancer Res., 39, 5063-5068.
47. Wood,A.W. et al. (1979) Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Cancer Res., 39, 4069-4077.
48. Carmella,S.G. et al. (2004) Analysis of phenanthrols in human urine by gas chromatography-mass spectrometry: Potential use in carcinogen metabolite phenotyping. Cancer Epidemiol. Biomarkers Prev. 13, 2167-2174.
49. Upadhyaya,P. et al. (2006) Quantitation of N-acetyl-S (9,10-dihydro-9- hydroxy-10-phenanduyl -L-cysteine in human urine: comparison with glutathione-S-transferase genotypes in smokers. Chem. Res. Toxicol., 19, 1234-1240.
50. Jacob.J. et al. (1999) Profile of urinary phenanthrene metabolites in smokers and non-smokers. Biomarkers, 4, 319-327.
51. Simpson,C.D. et al. (2000) Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9, 10-tetrahydrobenzo[a]pyrene in human urine by gas chromatography-negative ion chemical ionization-mass spectrometry. Chem. Res. Toxicol., 13, 271-280.